{
  "DOI": "10.1038/s41431-023-01320-0",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/s41431-023-01320-0",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:p\u003ePediatric Moyamoya Angiopathy (MMA) is a progressive intracranial occlusive arteriopathy that represents a leading cause of transient ischemic attacks and strokes in childhood. Despite this, up to now no large, exclusively pediatric MMA cohort has been subjected to systematic genetic investigation. In this study, we performed molecular karyotyping, exome sequencing and automated structural assessment of missense variants on a series of 88 pediatric MMA patients and correlated genetic, angiographic and clinical (stroke burden) findings. The two largest subgroups in our cohort consisted of\u003cjats:italic\u003eRNF213\u003c/jats:italic\u003eand neurofibromatosis type 1 (NF1) patients. While deleterious\u003cjats:italic\u003eRNF213\u003c/jats:italic\u003evariants were associated with a severe MMA clinical course with early symptom onset, frequent posterior cerebral artery involvement and higher stroke rates in multiple territories, NF1 patients had a similar infarct burden compared to non-NF1 individuals and were often diagnosed incidentally during routine MRIs. Additionally, we found that MMA-associated\u003cjats:italic\u003eRNF213\u003c/jats:italic\u003evariants have lower predicted functional impact compared to those associated with aortic disease. We also raise the question of MMA as a feature of recurrent as well as rare chromosomal imbalances and further support the possible association of MMA with\u003cjats:italic\u003eSTAT3\u003c/jats:italic\u003edeficiency. In conclusion, we provide a comprehensive characterization at the genetic and clinical level of a large exclusively pediatric MMA population. Due to the clinical differences found across genetic subgroups, we propose genetic testing for risk stratification as part of the routine assessment of pediatric MMA patients.\u003c/jats:p\u003e",
  "alternative-id": [
    "1320"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "29 June 2022"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Revised",
      "name": "revised",
      "order": 2,
      "value": "16 December 2022"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 3,
      "value": "13 February 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 4,
      "value": "4 April 2023"
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1,
      "value": "The authors declare no competing interests."
    },
    {
      "group": {
        "label": "Ethical approval",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "The study was conducted under approval of the Ethical Committee of the Canton of Zurich, ID# BASEC-2016-00880. Written informed consent for genetic testing and publication of genetic and clinical data was obtained from each individual’s parents or their legal guardian."
    }
  ],
  "author": [
    {
      "ORCID": "http://orcid.org/0000-0001-9397-1989",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Zanoni",
      "given": "Paolo",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Steindl",
      "given": "Katharina",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0001-5644-045X",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Sticht",
      "given": "Heinrich",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Oneda",
      "given": "Beatrice",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Joset",
      "given": "Pascal",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Ivanovski",
      "given": "Ivan",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0003-3539-8103",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Horn",
      "given": "Anselm H. C.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Cabello",
      "given": "Elena M.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Laube",
      "given": "Julia",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Zweier",
      "given": "Markus",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0001-5124-4740",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Baumer",
      "given": "Alessandra",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0003-2930-3163",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Rauch",
      "given": "Anita",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0001-5077-6622",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Khan",
      "given": "Nadia",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2023,
        4,
        4
      ]
    ],
    "date-time": "2023-04-04T02:02:28Z",
    "timestamp": 1680573748000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        12,
        10
      ]
    ],
    "date-time": "2023-12-10T05:01:25Z",
    "timestamp": 1702184485000
  },
  "funder": [
    {
      "DOI": "10.13039/501100006447",
      "award": [
        "Research Priority Program Itinerare"
      ],
      "doi-asserted-by": "publisher",
      "name": "Universität Zürich"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        10
      ]
    ],
    "date-time": "2024-04-10T10:31:34Z",
    "timestamp": 1712745094920
  },
  "is-referenced-by-count": 5,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "7",
  "issued": {
    "date-parts": [
      [
        2023,
        4,
        4
      ]
    ]
  },
  "journal-issue": {
    "issue": "7",
    "published-print": {
      "date-parts": [
        [
          2023,
          7
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2023,
            4,
            4
          ]
        ],
        "date-time": "2023-04-04T00:00:00Z",
        "timestamp": 1680566400000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2023,
            4,
            4
          ]
        ],
        "date-time": "2023-04-04T00:00:00Z",
        "timestamp": 1680566400000
      }
    }
  ],
  "link": [
    {
      "URL": "https://www.nature.com/articles/s41431-023-01320-0.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://www.nature.com/articles/s41431-023-01320-0",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://www.nature.com/articles/s41431-023-01320-0.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "784-792",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2023,
        4,
        4
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2023,
        4,
        4
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2023,
        7
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1056/NEJMra0804622",
      "author": "RM Scott",
      "doi-asserted-by": "publisher",
      "first-page": "1226",
      "journal-title": "N Engl J Med.",
      "key": "1320_CR1",
      "unstructured": "Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med. 2009;360:1226–37. http://www.ncbi.nlm.nih.gov/pubmed/19297575.",
      "volume": "360",
      "year": "2009"
    },
    {
      "DOI": "10.1002/ana.21981",
      "author": "SK Kim",
      "doi-asserted-by": "publisher",
      "first-page": "92",
      "journal-title": "Ann Neurol.",
      "key": "1320_CR2",
      "unstructured": "Kim SK, Cho BK, Phi JH, Lee JY, Chae JH, Kim KJ, et al. Pediatric moyamoya disease: an analysis of 410 consecutive cases. Ann Neurol. 2010;68:92–101. http://doi.wiley.com/10.1002/ana.21981.",
      "volume": "68",
      "year": "2010"
    },
    {
      "DOI": "10.5853/jos.2015.01627",
      "author": "JS Kim",
      "doi-asserted-by": "publisher",
      "first-page": "2",
      "journal-title": "J Stroke.",
      "key": "1320_CR3",
      "unstructured": "Kim JS. Moyamoya disease: epidemiology, clinical features, and diagnosis. J Stroke. 2016;18:2–11. http://www.ncbi.nlm.nih.gov/pubmed/26846755.",
      "volume": "18",
      "year": "2016"
    },
    {
      "DOI": "10.1136/jnnp-2011-301387",
      "doi-asserted-by": "crossref",
      "key": "1320_CR4",
      "unstructured": "Kleinloog, R, Regli, L, Rinkel, GJE, Klijn, CJM. Regional differences in incidence and patient characteristics of moyamoya disease: a systematic review. J Neurol Neurosurg Psychiatry. 2012;83:531–6. http://jnnp.bmj.com/."
    },
    {
      "DOI": "10.2176/jns-nmc.2022-0072",
      "author": "S Kuroda",
      "doi-asserted-by": "publisher",
      "first-page": "307",
      "journal-title": "Neurol Med Chir.",
      "key": "1320_CR5",
      "unstructured": "Kuroda S, Fujimura M, Takahashi J, Kataoka H, Ogasawara K, Iwama T, et al. Diagnostic criteria for moyamoya disease-2021 revised version. Neurol Med Chir. 2022;62:307–12. https://pubmed.ncbi.nlm.nih.gov/35613882/.",
      "volume": "62",
      "year": "2022"
    },
    {
      "DOI": "10.1007/s12975-021-00940-2",
      "doi-asserted-by": "crossref",
      "key": "1320_CR6",
      "unstructured": "Mertens R, Graupera M, Gerhardt H, Bersano A, Tournier-Lasserve E, Mensah MA, et al. The genetic basis of moyamoya disease. Transl Stroke Res. 2021;1:1–21. https://link.springer.com/article/10.1007/s12975-021-00940-2."
    },
    {
      "DOI": "10.2147/TACG.S252736",
      "doi-asserted-by": "crossref",
      "key": "1320_CR7",
      "unstructured": "Dorschel KB, Wanebo JE. Genetic and proteomic contributions to the pathophysiology of moyamoya angiopathy and related vascular diseases. Appl Clin Genet. 2021;14:145–71. https://pubmed.ncbi.nlm.nih.gov/33776470/."
    },
    {
      "DOI": "10.7554/eLife.56185",
      "author": "J Ahel",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Elife.",
      "key": "1320_CR8",
      "unstructured": "Ahel J, Lehner A, Vogel A, Schleiffer A, Meinhart A, Haselbach D, et al. Moyamoya disease factor RNF213 is a giant E3 ligase with a dynein-like core and a distinct ubiquitin-transfer mechanism. Elife. 2020;9:1–23. https://pubmed.ncbi.nlm.nih.gov/32573437/.",
      "volume": "9",
      "year": "2020"
    },
    {
      "DOI": "10.3389/fneur.2021.687088",
      "doi-asserted-by": "crossref",
      "key": "1320_CR9",
      "unstructured": "Mineharu Y, Miyamoto S. RNF213 and GUCY1A3 in moyamoya disease: key regulators of metabolism, inflammation, and vascular stability. Front Neurol. 2021;1. www.frontiersin.org."
    },
    {
      "DOI": "10.1534/g3.115.020321",
      "author": "LD Shoemaker",
      "doi-asserted-by": "publisher",
      "first-page": "41",
      "journal-title": "G3; Genes|Genomes|Genet",
      "key": "1320_CR10",
      "unstructured": "Shoemaker LD, Clark MJ, Patwardhan A, Chandratillake G, Garcia S, Chen R, et al. Disease variant landscape of a large multiethnic population of moyamoya patients by exome sequencing. G3; Genes|Genomes|Genet. 2016;6:41–9. http://www.ncbi.nlm.nih.gov/pubmed/26530418.",
      "volume": "6",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.jstrokecerebrovasdis.2018.04.013",
      "author": "Y Wang",
      "doi-asserted-by": "publisher",
      "first-page": "2259",
      "journal-title": "J Stroke Cerebrovasc Dis.",
      "key": "1320_CR11",
      "unstructured": "Wang Y, Mambiya M, Li Q, Yang L, Jia H, Han Y, et al. RNF213 p.R4810K polymorphism and the risk of moyamoya disease, intracranial major artery stenosis/occlusion, and quasi-moyamoya disease: a meta-analysis. J Stroke Cerebrovasc Dis. 2018;27:2259–70. https://pubmed.ncbi.nlm.nih.gov/29752070/.",
      "volume": "27",
      "year": "2018"
    },
    {
      "DOI": "10.1161/STROKEAHA.120.029527",
      "author": "X Wang",
      "doi-asserted-by": "publisher",
      "first-page": "1647",
      "journal-title": "Stroke.",
      "key": "1320_CR12",
      "unstructured": "Wang X, Wang Y, Nie F, Li Q, Zhang K, Liu M, et al. Association of genetic variants with moyamoya disease in 13 000 individuals: a meta-analysis. Stroke. 2020;51:1647–55. https://www.ahajournals.org/doi/10.1161/STROKEAHA.120.029527.",
      "volume": "51",
      "year": "2020"
    },
    {
      "DOI": "10.1038/ejhg.2017.92",
      "author": "S Guey",
      "doi-asserted-by": "publisher",
      "first-page": "995",
      "journal-title": "Eur J Hum Genet.",
      "key": "1320_CR13",
      "unstructured": "Guey S, Kraemer M, Hervé D, Ludwig T, Kossorotoff M, Bergametti F, et al. Rare RNF213 variants in the C-terminal region encompassing the RING-finger domain are associated with moyamoya angiopathy in Caucasians. Eur J Hum Genet. 2017;25:995–1003. http://www.ncbi.nlm.nih.gov/pubmed/28635953.",
      "volume": "25",
      "year": "2017"
    },
    {
      "DOI": "10.1161/STROKEAHA.114.006244",
      "author": "AC Cecchi",
      "doi-asserted-by": "publisher",
      "first-page": "3200",
      "journal-title": "Stroke.",
      "key": "1320_CR14",
      "unstructured": "Cecchi AC, Guo D, Ren Z, Flynn K, Santos-Cortez RLP, Leal SM, et al. RNF213 rare variants in an ethnically diverse population with moyamoya disease. Stroke. 2014;45:3200–7. https://pubmed.ncbi.nlm.nih.gov/25278557/.",
      "volume": "45",
      "year": "2014"
    },
    {
      "DOI": "10.1001/jamaneurol.2021.1681",
      "doi-asserted-by": "crossref",
      "key": "1320_CR15",
      "unstructured": "Kundishora AJ, Peters ST, Pinard A, Duran D, Panchagnula S, Barak T, et al. DIAPH1 variants in non–east asian patients with sporadic moyamoya disease. JAMA Neurol. 2021. https://pubmed.ncbi.nlm.nih.gov/34125151/."
    },
    {
      "DOI": "10.1111/cge.12739",
      "doi-asserted-by": "crossref",
      "key": "1320_CR16",
      "unstructured": "Wallace S, Guo D-C, Regalado E, Mellor-Crummey L, Bamshad M, Nickerson DA, et al. Disrupted nitric oxide signaling due to GUCY1A3 mutations increases risk for moyamoya disease, achalasia and hypertension. Clin Genet. 2016;90:351–60. http://doi.wiley.com/10.1111/cge.12739."
    },
    {
      "DOI": "10.1182/blood-2014-02-553685",
      "doi-asserted-by": "crossref",
      "key": "1320_CR17",
      "unstructured": "Janczar S, Fogtman A, Koblowska M, Baranska D, Pastorczak A, Wegner O, et al. Novel severe hemophilia a and moyamoya (SHAM) syndrome caused by Xq28 deletions encompassing F8 and BRCC3 genes. Blood. 2014;123:4002–4. https://ashpublications.org/blood/article/123/25/4002/32891/Novel-severe-hemophilia-A-and-moyamoya-SHAM."
    },
    {
      "DOI": "10.1038/s41436-019-0639-2",
      "author": "A Pinard",
      "doi-asserted-by": "publisher",
      "first-page": "427",
      "journal-title": "Genet Med",
      "key": "1320_CR18",
      "unstructured": "Pinard A, Guey S, Guo D, Cecchi AC, Kharas N, Wallace S, et al. The pleiotropy associated with de novo variants in CHD4, CNOT3, and SETD5 extends to moyamoya angiopathy. Genet Med. 2020;22:427–31.",
      "volume": "22",
      "year": "2020"
    },
    {
      "DOI": "10.1136/jmedgenet-2019-106525",
      "author": "C Aloui",
      "doi-asserted-by": "publisher",
      "first-page": "339",
      "journal-title": "J Med Genet",
      "key": "1320_CR19",
      "unstructured": "Aloui C, Guey S, Pipiras E, Kossorotoff M, Guéden S, Corpechot M, et al. Xq28 copy number gain causing moyamoya disease and a novel moyamoya syndrome. J Med Genet. 2020;57:339–46.",
      "volume": "57",
      "year": "2020"
    },
    {
      "DOI": "10.1136/jmedgenet-2016-104432",
      "author": "S Guey",
      "doi-asserted-by": "publisher",
      "first-page": "550",
      "journal-title": "J Med Genet.",
      "key": "1320_CR20",
      "unstructured": "Guey S, Grangeon L, Brunelle F, Bergametti F, Amiel J, Lyonnet S, et al. De novo mutations in CBL causing early-onset paediatric moyamoya angiopathy. J Med Genet. 2017;54:550–7. http://www.ncbi.nlm.nih.gov/pubmed/28343148.",
      "volume": "54",
      "year": "2017"
    },
    {
      "DOI": "10.1007/s12975-019-00743-6",
      "doi-asserted-by": "crossref",
      "key": "1320_CR21",
      "unstructured": "Bang OY, Chung JW, Kim DH, Won HH, Yeon JY, Ki CS, et al. Moyamoya disease and spectrums of RNF213 vasculopathy. Transl Stroke Res. 2020;11:580–9. https://pubmed.ncbi.nlm.nih.gov/31650369/."
    },
    {
      "DOI": "10.1038/s41436-019-0464-7",
      "author": "P Boonsawat",
      "doi-asserted-by": "publisher",
      "first-page": "2043",
      "journal-title": "Genet Med.",
      "key": "1320_CR22",
      "unstructured": "Boonsawat P, Joset P, Steindl K, Oneda B, Gogoll L, Azzarello-Burri S, et al. Elucidation of the phenotypic spectrum and genetic landscape in primary and secondary microcephaly. Genet Med. 2019;21:2043–58. http://www.ncbi.nlm.nih.gov/pubmed/30842647.",
      "volume": "21",
      "year": "2019"
    },
    {
      "DOI": "10.1161/STROKEAHA.117.017430",
      "author": "L Duan",
      "doi-asserted-by": "publisher",
      "first-page": "11",
      "journal-title": "Stroke.",
      "key": "1320_CR23",
      "unstructured": "Duan L, Wei L, Tian Y, Zhang Z, Hu P, Wei Q, et al. Novel susceptibility loci for moyamoya disease revealed by a genome-wide association study. Stroke. 2018;49:11–8. http://www.ncbi.nlm.nih.gov/pubmed/29273593.",
      "volume": "49",
      "year": "2018"
    },
    {
      "DOI": "10.1038/gim.2015.30",
      "doi-asserted-by": "crossref",
      "key": "1320_CR24",
      "unstructured": "Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–24. www.lrg-sequence.org."
    },
    {
      "DOI": "10.1093/nar/gky1016",
      "author": "P Rentzsch",
      "doi-asserted-by": "publisher",
      "first-page": "D886",
      "journal-title": "Nucleic Acids Res.",
      "key": "1320_CR25",
      "unstructured": "Rentzsch P, Witten D, Cooper GM, Shendure J, Kircher M. CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res. 2019;47:D886–94. https://cadd.gs.washington.edu.",
      "volume": "47",
      "year": "2019"
    },
    {
      "DOI": "10.1093/nar/gkw120",
      "author": "EH Baugh",
      "doi-asserted-by": "publisher",
      "first-page": "2501",
      "journal-title": "Nucleic Acids Res.",
      "key": "1320_CR26",
      "unstructured": "Baugh EH, Simmons-Edler R, Müller CL, Alford RF, Volfovsky N, Lash AE, et al. Robust classification of protein variation using structural modelling and large-scale data integration. Nucleic Acids Res. 2016;44:2501–13. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4824117/.",
      "volume": "44",
      "year": "2016"
    },
    {
      "key": "1320_CR27",
      "unstructured": "Miller DT, Chung W, Nasir R, Shen Y, Steinman KJ, Wu B-L, et al. 16p11.2 Recurrent microdeletion. GeneReviews®. 1993. http://www.ncbi.nlm.nih.gov/pubmed/20301775."
    },
    {
      "DOI": "10.1016/j.ejmg.2015.08.004",
      "author": "A Van Dijck",
      "doi-asserted-by": "publisher",
      "first-page": "503",
      "journal-title": "Eur J Med Genet.",
      "key": "1320_CR28",
      "unstructured": "Van Dijck A, van der Werf IM, Reyniers E, Scheers S, Azage M, Siefkas K, et al. Five patients with a chromosome 1q21.1 triplication show macrocephaly, increased weight and facial similarities. Eur J Med Genet. 2015;58:503–8. https://reader.elsevier.com/reader/sd/pii/S1769721215300112?token=2E681C19075D311C072D2FA40C241D290651CD6300438BEC23ABD73E78AF50D085D773AB13ECD245184DB4DA3A54FD61\u0026originRegion=eu-west-1\u0026originCreation=20211207145616.",
      "volume": "58",
      "year": "2015"
    },
    {
      "DOI": "10.1038/nature12818",
      "author": "H Stefansson",
      "doi-asserted-by": "publisher",
      "first-page": "361",
      "journal-title": "Nature.",
      "key": "1320_CR29",
      "unstructured": "Stefansson H, Meyer-Lindenberg A, Steinberg S, Magnusdottir B, Morgen K, Arnarsdottir S, et al. CNVs conferring risk of autism or schizophrenia affect cognition in controls. Nature. 2014;505:361–6. http://www.ncbi.nlm.nih.gov/pubmed/24352232.",
      "volume": "505",
      "year": "2014"
    },
    {
      "DOI": "10.1371/journal.pone.0022542",
      "doi-asserted-by": "crossref",
      "key": "1320_CR30",
      "unstructured": "Liu W, Morito D, Takashima S, Mineharu Y, Kobayashi H, Hitomi T, et al. Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. Meisel A, editor. PLoS ONE. 2011;6:e22542. https://pubmed.ncbi.nlm.nih.gov/21799892/."
    },
    {
      "DOI": "10.1371/journal.pgen.1008436",
      "doi-asserted-by": "crossref",
      "key": "1320_CR31",
      "unstructured": "Vilariño-Güell C, Zimprich A, Martinelli-Boneschi F, Herculano B, Wang Z, Matesanz F, et al. Expression of concern: Exome sequencing in multiple sclerosis families identifies 12 candidate genes and nominates biological pathways for the genesis of disease. PLoS Genet. 2019;15. https://pubmed.ncbi.nlm.nih.gov/31170158/."
    },
    {
      "DOI": "10.1371/journal.pgen.1008180",
      "doi-asserted-by": "publisher",
      "key": "1320_CR32",
      "unstructured": "Erratum: Exome sequencing in multiple sclerosis families identifies 12 candidate genes and nominates biological pathways for the genesis of disease (PLoS Genetics (2019) 15:6 (e1008180), https://doi.org/10.1371/journal.pgen.1008180). PLoS Genet. 2020;16."
    },
    {
      "DOI": "10.1161/HYPERTENSIONAHA.117.10296",
      "author": "JK Warejko",
      "doi-asserted-by": "publisher",
      "first-page": "691",
      "journal-title": "Hypertension.",
      "key": "1320_CR33",
      "unstructured": "Warejko JK, Schueler M, Vivante A, Tan W, Daga A, Lawson JA, et al. Whole exome sequencing reveals a monogenic cause of disease in ∼43% of 35 families with Midaortic syndrome. Hypertension. 2018;71:691–9. https://pubmed.ncbi.nlm.nih.gov/29483232/.",
      "volume": "71",
      "year": "2018"
    },
    {
      "DOI": "10.1093/ndt/gfq271",
      "author": "CE Kashtan",
      "doi-asserted-by": "publisher",
      "first-page": "3554",
      "journal-title": "Nephrol Dial Transpl.",
      "key": "1320_CR34",
      "unstructured": "Kashtan CE, Segal Y, Flinter F, Makanjuola D, Gan JS, Watnick T. Aortic abnormalities in males with Alport syndrome. Nephrol Dial Transpl. 2010;25:3554–60.",
      "volume": "25",
      "year": "2010"
    },
    {
      "DOI": "10.1159/000493863",
      "author": "JA Cuoco",
      "doi-asserted-by": "publisher",
      "first-page": "159",
      "journal-title": "Cerebrovasc Dis.",
      "key": "1320_CR35",
      "unstructured": "Cuoco JA, Busch CM, Klein BJ, Benko MJ, Stein R, Nicholson AD, et al. ACTA2 cerebral arteriopathy: not just a puff of smoke. Cerebrovasc Dis. 2018;46:159–69. http://www.ncbi.nlm.nih.gov/pubmed/30300893.",
      "volume": "46",
      "year": "2018"
    },
    {
      "DOI": "10.1016/S1474-4422(22)00165-X",
      "doi-asserted-by": "crossref",
      "key": "1320_CR36",
      "unstructured": "Ihara M, Yamamoto Y, Hattori Y, Liu W, Kobayashi H, Ishiyama H, et al. Moyamoya disease: diagnosis and interventions. Lancet Neurol. 2022;21:747–58. https://pubmed.ncbi.nlm.nih.gov/35605621/."
    },
    {
      "DOI": "10.1212/NXG.0000000000200017",
      "doi-asserted-by": "crossref",
      "key": "1320_CR37",
      "unstructured": "Ikeuchi Y, Kitayama J, Sahara N, Okata T, Miyake N, Matsumoto N, et al. Filamin A variant as a possible second-hit gene promoting moyamoya disease–like vascular formation associated with RNF213 p.R4810K variant. Neurol Genet. 2022;8. https://pubmed.ncbi.nlm.nih.gov/36101542/."
    },
    {
      "DOI": "10.1212/WNL.0000000000008901",
      "author": "Y Wang",
      "doi-asserted-by": "publisher",
      "first-page": "e678",
      "journal-title": "Neurology",
      "key": "1320_CR38",
      "unstructured": "Wang Y, Zhang Z, Wei L, Zhang Q, Zou Z, Yang L, et al. Predictive role of heterozygous p.R4810K of RNF213 in the phenotype of Chinese moyamoya disease. Neurology. 2020;94:e678–86. https://n.neurology.org/content/94/7/e678.",
      "volume": "94",
      "year": "2020"
    },
    {
      "DOI": "10.1016/j.pediatrneurol.2021.03.002",
      "author": "ML Kaseka",
      "doi-asserted-by": "publisher",
      "first-page": "18",
      "journal-title": "Pediatr Neurol",
      "key": "1320_CR39",
      "unstructured": "Kaseka ML, Slim M, Muthusami P, Dirks PB, Westmacott R, Kassner A, et al. Distinct clinical and radiographic phenotypes in pediatric patients with moyamoya. Pediatr Neurol. 2021;120:18–26.",
      "volume": "120",
      "year": "2021"
    },
    {
      "DOI": "10.1016/j.jstrokecerebrovasdis.2016.07.004",
      "author": "T Morimoto",
      "doi-asserted-by": "publisher",
      "first-page": "2632",
      "journal-title": "J Stroke Cerebrovasc Dis",
      "key": "1320_CR40",
      "unstructured": "Morimoto T, Mineharu Y, Kobayashi H, Harada KH, Funaki T, Takagi Y, et al. Significant association of the RNF213 p.R4810K polymorphism with quasi-moyamoya disease. J Stroke Cerebrovasc Dis. 2016;25:2632–6.",
      "volume": "25",
      "year": "2016"
    },
    {
      "DOI": "10.1038/s41593-020-0663-1",
      "author": "J Ouellette",
      "doi-asserted-by": "publisher",
      "first-page": "1090",
      "journal-title": "Nat Neurosci",
      "key": "1320_CR41",
      "unstructured": "Ouellette J, Toussay X, Comin CH, Costa L, da F, Ho M, et al. Vascular contributions to 16p11.2 deletion autism syndrome modeled in mice. Nat Neurosci. 2020;23:1090–101.",
      "volume": "23",
      "year": "2020"
    },
    {
      "DOI": "10.3389/fimmu.2018.00184",
      "author": "N Bhaskaran",
      "doi-asserted-by": "publisher",
      "first-page": "184",
      "journal-title": "Front Immunol",
      "key": "1320_CR42",
      "unstructured": "Bhaskaran N, Liu Z, Saravanamuthu SS, Yan C, Hu Y, Dong L, et al. Identification of Casz1 as a regulatory protein controlling T Helper cell differentiation, inflammation, and immunity. Front Immunol. 2018;9:184.",
      "volume": "9",
      "year": "2018"
    },
    {
      "DOI": "10.1038/onc.2016.179",
      "doi-asserted-by": "crossref",
      "key": "1320_CR43",
      "unstructured": "Liu Z, Lam N, Wang E, Virden RA, Pawel B, Attiyeh EF, et al. Identification of CASZ1 NES reveals potential mechanisms for loss of CASZ1 tumor suppressor activity in neuroblastoma. Oncogene. 2017;36:97–109. www.nature.com/onc."
    },
    {
      "DOI": "10.1002/mgg3.828",
      "author": "J Guo",
      "doi-asserted-by": "crossref",
      "first-page": "e828",
      "journal-title": "Mol Genet Genom Med.",
      "key": "1320_CR44",
      "unstructured": "Guo J, Li Z, Hao C, Guo R, Hu X, Qian S, et al. A novel de novo CASZ1 heterozygous frameshift variant causes dilated cardiomyopathy and left ventricular noncompaction cardiomyopathy. Mol Genet Genom Med. 2019;7:e828 https://onlinelibrary.wiley.com/doi/full/10.1002/mgg3.828.",
      "volume": "7",
      "year": "2019"
    },
    {
      "DOI": "10.1212/NXG.0000000000000509",
      "doi-asserted-by": "crossref",
      "key": "1320_CR45",
      "unstructured": "Mo XB, Zhang H, Wang AL, Xu T, Zhang YH. Integrative analysis identifies the association between CASZ1 methylation and ischemic stroke. Neurol Genet. 2020;6. https://ng.neurology.org/content/6/5/e509."
    },
    {
      "DOI": "10.1016/j.ajhg.2019.04.011",
      "author": "D Monies",
      "doi-asserted-by": "publisher",
      "first-page": "1182",
      "journal-title": "Am J Hum Genet",
      "key": "1320_CR46",
      "unstructured": "Monies D, Abouelhoda M, Assoum M, Moghrabi N, Rafiullah R, Almontashiri N, et al. Lessons learned from large-scale, first-tier clinical exome sequencing in a highly consanguineous population. Am J Hum Genet. 2019;104:1182–201.",
      "volume": "104",
      "year": "2019"
    },
    {
      "DOI": "10.1016/j.jaci.2019.11.042",
      "author": "AA Mauracher",
      "doi-asserted-by": "publisher",
      "first-page": "1297",
      "journal-title": "J Allergy Clin Immunol.",
      "key": "1320_CR47",
      "unstructured": "Mauracher AA, Eekels JJM, Woytschak J, van Drogen A, Bosch A, Prader S, et al. Erythropoiesis defect observed in STAT3 GOF patients with severe anemia. J Allergy Clin Immunol. 2020;145:1297–301. https://pubmed.ncbi.nlm.nih.gov/31857100/.",
      "volume": "145",
      "year": "2020"
    },
    {
      "DOI": "10.1186/s12920-018-0385-3",
      "doi-asserted-by": "crossref",
      "key": "1320_CR48",
      "unstructured": "Uchino H, Ito M, Kazumata K, Hama Y, Hamauchi S, Terasaka S, et al. Circulating miRNome profiling in Moyamoya disease-discordant monozygotic twins and endothelial microRNA expression analysis using iPS cell line. BMC Med Genomics. 2018;11. https://pubmed.ncbi.nlm.nih.gov/30157848/."
    },
    {
      "DOI": "10.1161/CIRCULATIONAHA.114.013003",
      "author": "CJ Hoffmann",
      "doi-asserted-by": "publisher",
      "first-page": "1772",
      "journal-title": "Circulation.",
      "key": "1320_CR49",
      "unstructured": "Hoffmann CJ, Harms U, Rex A, Szulzewsky F, Wolf SA, Grittner U, et al. Vascular signal transducer and activator of transcription-3 promotes angiogenesis and neuroplasticity long-term after stroke. Circulation. 2015;131:1772–82. https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.114.013003.",
      "volume": "131",
      "year": "2015"
    },
    {
      "DOI": "10.3171/2016.12.PEDS16468",
      "author": "J Gaillard",
      "doi-asserted-by": "publisher",
      "first-page": "553",
      "journal-title": "J Neurosurg Pediatr",
      "key": "1320_CR50",
      "unstructured": "Gaillard J, Klein J, Duran D, Storey A, Scott RM, Kahle K, et al. Incidence, clinical features, and treatment of familial moyamoya in pediatric patients: a single-institution series. J Neurosurg Pediatr. 2017;19:553–9. https://pubmed.ncbi.nlm.nih.gov/28291427/.",
      "volume": "19",
      "year": "2017"
    }
  ],
  "reference-count": 50,
  "references-count": 50,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/s41431-023-01320-0"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "The genetic landscape and clinical implication of pediatric Moyamoya angiopathy in an international cohort"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "31"
}